| Literature DB >> 36233870 |
Bianca Nobis1,2, Thomas Ostermann3, Julian Weiler2, Thomas Dittmar2, Anton Friedmann1,2.
Abstract
The aim of this study was to investigate the impact of cross-linked hyaluronic acid on osteoblast-like cells seeded on top of two collagen substrates, native porcine pericardium membrane (substrate A) and ribose cross-linked collagen membranes (substrate B), in an air-lift model. Substrates A or B, saturated with three hyaluronic acid concentrations, served as membranes for SAOS-2 cells seeded on top. Cultivation followed for 7 and 14 days in the air-lift model. Controls used the same substrates without hyaluronic pre-treatment. Cells were harvested, and four (Runx2, BGLAP, IBSP, Cx43) different osteogenic differentiation markers were assessed by qPCR. Triplicated experiment outcomes were statistically analyzed (ANOVA, t-test; SPSS). Supplementary histologic analysis confirmed the cells' vitality. After seven days, only few markers were overexpressed on both substrates. After 14 days, targeted genes were highly expressed on substrate A. The same substrate treated with 1:100 diluted xHyA disclosed statistically significant different expression level vs. substrate B (p = 0.032). Time (p = 0.0001), experimental condition as a function of time (p = 0.022), and substrate (p = 0.028) were statistically significant factors. Histological imaging demonstrated vitality and visualized nuclei. We conclude that the impact of hyaluronic acid resulted in a higher expression profile of SAOS-2 cells on substrate A compared to substrate B in an air-lift culture after two weeks.Entities:
Keywords: SAOS-2 cells; air-lift organoid model; cross-linked collagen substrate; cross-linked hyaluronic acid; osteogenic differentiation
Year: 2022 PMID: 36233870 PMCID: PMC9572243 DOI: 10.3390/ma15196528
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.748
Figure 1Test conditions disclosed for a single well with the installed insert on a 6-well plate.
Figure 2Schematic air-lift model *Substrate A (NPCM +/− xHyA); B (RCCM +/− xHyA).
Summary of pPCR primers.
| Name | Primer | Sequence (5′ to 3′) |
|---|---|---|
| Cx43 | forward | CCT TCT TGC TGA TCC AGT GGT AC |
| reverse | ACC AAG GAC ACC AVV AGC AT | |
| BGLAP | forward | TTC TTT CCT CTT CCC CTT G |
| reverse | CCT CTT CTG GAG TTT ATT TGG | |
| IBSP | forward | GGA GAC TTC AAA TGA AGG AG |
| reverse | CAG AAA GTG TGG TAT TCT CAG | |
| Runx2 | forward | CCA ACC CAC GAA TGC ACT ATC |
| reverse | TAG TGA GTG GTG GCG GAC ATA C | |
| GAPDH | forward | TGC ACC ACC AAC TGC TTA GC |
| reverse | GGC ATG GAC TGT GGT CAT GAG |
Figure 3Relative expression differences of the target genes to the housekeeping gene GAPDH compared to the positive control in cells from the substrate A (NPCM, left) and substrate B (RCCM, right) after 7 and 14 days. (A) xHyA in 1_1 dilution used on substrate A enhanced only Runx2 expression by factor 4 at T1, (B) on the substrate B only BGLAP displayed enhanced expression rate under xHyA at 1_100 dilution at T1, (C) xHyA dilutions of 1_10 and 1_1 on substrate A upraised the expression of Runx2 and BGLAP to 120 and 44 fold, respectively, while highest level of Cx43 expression was measured at 1_100 dilution of xHyA, (D) only BGLAP showed increased expression on the substrate B treated with 1_1 xHyA.
Figure 4The statistically significant difference in the −ΔΔCT scores between the two substrates.
Figure 5Toluidine blue staining of SAOS-2 cells adhered to the substrate B after 14 days (left) and hemalum-eosin staining of SAOS-2 cells on the same substrate B (right).